Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Painreform Ltd (PRFX)

Painreform Ltd (PRFX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PainReform to Present at the Microcap Conference in Atlantic City Newsfile - Mon Jan 22, 7:40AM CST

Tel Aviv, Israel--(Newsfile Corp. - January 22, 2024) - PainReform Ltd. (NASDAQ: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...

PRFX : 0.8550 (+1.79%)
PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th Globe Newswire - Tue Apr 12, 2022

TEL AVIV, Israel, April 12, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company focused on the...

PRFX : 0.8550 (+1.79%)
PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th Globe Newswire - Mon Mar 21, 2022

TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...

PRFX : 0.8550 (+1.79%)
PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022 Globe Newswire - Thu Mar 17, 2022

TEL AVIV, Israel, March 17, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...

PRFX : 0.8550 (+1.79%)
PainReform CEO to Participate in the Benzinga All Access Event on December 16th Globe Newswire - Tue Dec 14, 2021

TEL AVIV, Israel, Dec. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...

PRFX : 0.8550 (+1.79%)
PainReform Provides Business Update for the Third Quarter of 2021 Globe Newswire - Tue Nov 16, 2021

Reports continued progress towards commencing Phase 3 clinical trials Announces Selection of Pharmaceutics International, Inc. as U.S. Manufacturer of...

PRFX : 0.8550 (+1.79%)
PainReform to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021 Globe Newswire - Thu Oct 14, 2021

TEL AVIV, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...

PRFX : 0.8550 (+1.79%)
PainReform Provides Business Update for the Second Quarter of 2021 Globe NewsWire - Mon Aug 16, 2021

Shifting manufacturing and scale up operation to U.S.-based Contract Development and Manufacturing Organization for PRF-110

PRFX : 0.8550 (+1.79%)
PainReform Provides Business Update for the First Quarter of 2021 Globe NewsWire - Thu May 13, 2021

Reports continued progress towards start of Phase 3 trials

PRFX : 0.8550 (+1.79%)
PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief Globe NewsWire - Thu Mar 18, 2021

HERZLIYA, Israel, March 18, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation...

PRFX : 0.8550 (+1.79%)

Barchart Exclusives

Should Amazon Stock Follow The ‘Magnificent 7’ Trend and Start Paying a Dividend? Barchart - Tue May 7, 6:30PM CDT
While fellow 'Magnificent 7' peers like Alphabet and Meta Platforms have recently initiated dividends, Amazon might not do so for at least the next couple of years. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot